TGFB1 and neoplasm: Depletion of ATP6V0A1 diminishes the ability of Dac to reduce the levels of 24-OHC and TGF-β1 in CRC cells, thereby impeding its capacity to suppress CRC growth and restore anti-tumor activity in in vivo models.